Dipeptidyl peptidase‐4 inhibitors as preferable oral hypoglycemic agents in terms of treatment satisfaction: Results from a multicenter, 12‐week, open label, randomized controlled study in Japan (PREFERENCE 4 study)

Publisher: John Wiley & Sons Inc

E-ISSN: 2040-1124|9|1|137-145

ISSN: 2040-1116

Source: Journal Of Diabetes Investigation, Vol.9, Iss.1, 2018-01, pp. : 137-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content